Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial

Objective – to evaluate efficacy and safety of “Carmolis” fluid and gel in patients with knee osteoarthritis, as well as the gel efficacy combined with ultraphonophoresis.Materials and methods. The study included 200 patients, who were divided into 2 groups depending on the way of application of “Ca...

Full description

Saved in:
Bibliographic Details
Main Authors: L. N. Denisov, V. N. Sorotskaya, E. A. Leonova, L. V. Меn’shykova, M. L. Sukhareva, S. I. Glukhova, A. M. Lila
Format: Article
Language:Russian
Published: ABV-press 2020-05-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/424
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772538799849472
author L. N. Denisov
V. N. Sorotskaya
E. A. Leonova
L. V. Меn’shykova
M. L. Sukhareva
S. I. Glukhova
A. M. Lila
author_facet L. N. Denisov
V. N. Sorotskaya
E. A. Leonova
L. V. Меn’shykova
M. L. Sukhareva
S. I. Glukhova
A. M. Lila
author_sort L. N. Denisov
collection DOAJ
description Objective – to evaluate efficacy and safety of “Carmolis” fluid and gel in patients with knee osteoarthritis, as well as the gel efficacy combined with ultraphonophoresis.Materials and methods. The study included 200 patients, who were divided into 2 groups depending on the way of application of “Carmolis” forms. Group 1 included 165 patients with knee osteoarthritis (the main group included 90 patients, the control group – 75 patients), who underwent complex local treatment with 2 “Carmolis” forms. Group 2 included 35 patients (20 people in the main group and 15 in the control one). The main group received phonophoresis with “Carmolis” gel, and the control group received “Carmolis” gel locally on the affected knee joint. Patients’ average age in group 1 was 62,7 ± 8,5 years, the average age in the control group was 61.4 ± 8.7 years, the disease duration was 10.1 ± 4.7 and 9.2 ± 6, 0 years, respectively. In group 2 the average age and disease duration were 60.1 ± 12.8 and 5.7 ± 5.4 years, respectively.At the initial stage 90 patients of the main group 1 were rubbed “Carmolis” fluid locally in the joint followed by massage. After the fluid absorbed completely, “Carmolis” gel was applied, followed by massage. In the comparison group (75 patients), standard therapy was combined only with “Carmolis” fluid applied on the II knee joint.Twenty patients of the main group 2 were treated with phonophoresis combined with “Carmolis” gel. Clinical efficacy was assessed by pain dynamics.Results. Treatment with two “Carmolis” local forms significantly decreased average on moving from 61.8 ± 14.2 to 30.7 ± 14.2 (р <0,001), at rest – from 49 ± 19, 9 to 20.4 ± 8.5 (р <0,001), on palpation – from 38.7 ± 10.4 to 18.4 ± 5.7 (р <0,001). A similar dynamics was also revealed during WOMAC assessment (Western Ontario McMaster Universities OA Index). Before the treatment start the average WOMAC pain level in the main group was 240.5 ± 39.8, after the treatment – 114.8 ± 30.4 (р <0,001). The control group also showed pain decrease, but to a much lesser extent than in the main one. At the end of the treatment course, patients of both groups demonstrated a pronounced decrease of synovitis sings, but there were no differences between the groups. The dose of non-steroidal anti-inflammatory drugs in the main group was reduced in 70 (77.8 %) patients, in the control group – in 50 (66.7 %). The tolerability of both forms was very good and good. No adverse events were registered. Data on the effectiveness and safety of “Carmolis” gel combined with ultraphonophoresis are presented in the article.Conclusion. According to the results, combined therapy using “Carmolis” liquid and gel significantly reduces joint pain and synovitis severity, increases joints» functional ability and improves patients» general condition, which allows reducing the dose of non-steroidal anti-inflammatory drugs. Both “Carmolis” forms had excellent and good tolerability.
format Article
id doaj-art-c5f91c2b45064ec3b25b08b31b6c254d
institution DOAJ
issn 1818-8338
language Russian
publishDate 2020-05-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj-art-c5f91c2b45064ec3b25b08b31b6c254d2025-08-20T03:02:18ZrusABV-pressKlinicist1818-83382020-05-01141-210010610.17650/1818-8338-2020-14-1-2-100-106342Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trialL. N. Denisov0V. N. Sorotskaya1E. A. Leonova2L. V. Меn’shykova3M. L. Sukhareva4S. I. Glukhova5A. M. Lila6V.A. Nasonova Research Institute of RheumatologyTula State UniversityTolyatti City Hospital FourIrkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Federal State Budgetary Academy of Contitution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian FederationV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyObjective – to evaluate efficacy and safety of “Carmolis” fluid and gel in patients with knee osteoarthritis, as well as the gel efficacy combined with ultraphonophoresis.Materials and methods. The study included 200 patients, who were divided into 2 groups depending on the way of application of “Carmolis” forms. Group 1 included 165 patients with knee osteoarthritis (the main group included 90 patients, the control group – 75 patients), who underwent complex local treatment with 2 “Carmolis” forms. Group 2 included 35 patients (20 people in the main group and 15 in the control one). The main group received phonophoresis with “Carmolis” gel, and the control group received “Carmolis” gel locally on the affected knee joint. Patients’ average age in group 1 was 62,7 ± 8,5 years, the average age in the control group was 61.4 ± 8.7 years, the disease duration was 10.1 ± 4.7 and 9.2 ± 6, 0 years, respectively. In group 2 the average age and disease duration were 60.1 ± 12.8 and 5.7 ± 5.4 years, respectively.At the initial stage 90 patients of the main group 1 were rubbed “Carmolis” fluid locally in the joint followed by massage. After the fluid absorbed completely, “Carmolis” gel was applied, followed by massage. In the comparison group (75 patients), standard therapy was combined only with “Carmolis” fluid applied on the II knee joint.Twenty patients of the main group 2 were treated with phonophoresis combined with “Carmolis” gel. Clinical efficacy was assessed by pain dynamics.Results. Treatment with two “Carmolis” local forms significantly decreased average on moving from 61.8 ± 14.2 to 30.7 ± 14.2 (р <0,001), at rest – from 49 ± 19, 9 to 20.4 ± 8.5 (р <0,001), on palpation – from 38.7 ± 10.4 to 18.4 ± 5.7 (р <0,001). A similar dynamics was also revealed during WOMAC assessment (Western Ontario McMaster Universities OA Index). Before the treatment start the average WOMAC pain level in the main group was 240.5 ± 39.8, after the treatment – 114.8 ± 30.4 (р <0,001). The control group also showed pain decrease, but to a much lesser extent than in the main one. At the end of the treatment course, patients of both groups demonstrated a pronounced decrease of synovitis sings, but there were no differences between the groups. The dose of non-steroidal anti-inflammatory drugs in the main group was reduced in 70 (77.8 %) patients, in the control group – in 50 (66.7 %). The tolerability of both forms was very good and good. No adverse events were registered. Data on the effectiveness and safety of “Carmolis” gel combined with ultraphonophoresis are presented in the article.Conclusion. According to the results, combined therapy using “Carmolis” liquid and gel significantly reduces joint pain and synovitis severity, increases joints» functional ability and improves patients» general condition, which allows reducing the dose of non-steroidal anti-inflammatory drugs. Both “Carmolis” forms had excellent and good tolerability.https://klinitsist.abvpress.ru/Klin/article/view/424osteoarthritisknee osteoarthritissynovitis“carmolis” fluid“carmolis” gelultraphonophoresisnon-steroidal anti-inflammatory drugschondroprotectorslocal therapylikert scale assessment of osteoarthritis activity
spellingShingle L. N. Denisov
V. N. Sorotskaya
E. A. Leonova
L. V. Меn’shykova
M. L. Sukhareva
S. I. Glukhova
A. M. Lila
Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
Klinicist
osteoarthritis
knee osteoarthritis
synovitis
“carmolis” fluid
“carmolis” gel
ultraphonophoresis
non-steroidal anti-inflammatory drugs
chondroprotectors
local therapy
likert scale assessment of osteoarthritis activity
title Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
title_full Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
title_fullStr Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
title_full_unstemmed Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
title_short Efficacy and safety of two “Carmolis” forms for combined local therapy of knee osteoarthritis: results of a multicenter clinical trial
title_sort efficacy and safety of two carmolis forms for combined local therapy of knee osteoarthritis results of a multicenter clinical trial
topic osteoarthritis
knee osteoarthritis
synovitis
“carmolis” fluid
“carmolis” gel
ultraphonophoresis
non-steroidal anti-inflammatory drugs
chondroprotectors
local therapy
likert scale assessment of osteoarthritis activity
url https://klinitsist.abvpress.ru/Klin/article/view/424
work_keys_str_mv AT lndenisov efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT vnsorotskaya efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT ealeonova efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT lvmenshykova efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT mlsukhareva efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT siglukhova efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial
AT amlila efficacyandsafetyoftwocarmolisformsforcombinedlocaltherapyofkneeosteoarthritisresultsofamulticenterclinicaltrial